In the present study, we administered Lycium barbarum glycopeptide to a mouse model of experimental autoimmune encephalomyelitis-an animal model of multiple sclerosis-and evaluated its effects on pathogenic CD4 + T cell activation both in vivo and in vitro . The gene discussed is CD4; the disease is multiple sclerosis.